SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2 - Kidney International
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19: Molecular Therapy - Methods & Clinical Development
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons | Hypertension
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 | NEJM
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Viruses | Free Full-Text | ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
ACE2: Targeting a Potentially Important Receptor in Disease Pathogenesis | CAS
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
ACE2 mouse models: a toolbox for cardiovascular and pulmonary research | Nature Communications
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications - ScienceDirect
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System | Circulation Research
Manipulation of ACE2 expression in COVID-19 | Open Heart
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection | SpringerLink
Men's blood contains greater concentrations o | EurekAlert!
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries | Hypertension
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
Oral Mucosa Shows High Expression of ACE2 Receptor of 2019-nCoV | PracticeUpdate
Pathways: ACE Inhibitor Pathway | www.antibodies-online.com
Frontiers | Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?
ACE2: Targeting a Potentially Important Receptor in Disease Pathogenesis | CAS
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications - ScienceDirect
